Darwin-Nogol (brand)

Darwin Nogao (Beijing) Biotechnology Co., Ltd. is Darwin Cell Biology Group's biomaterials production base, which is a "bio-wise factory" integrating independent research and development capability, scientific and technological innovation capability, industrial transformation capability, and product market transformation capability.

Darwin Nogol is located in Zhongguancun Medical Device Industrial Park, Daxing District, covering an area of nearly 2,000 square meters, and has a high level biomaterials production line that is fully compliant with the GMP certification for pharmaceuticals and medical devices at the international level. Darwin Nogol has built aseptic automatic production lines - liquid dispensing system, vertical ultrasonic cleaning machine, tunnel sterilization dryer, vial filling and corking machine, automatic feeding and discharging system, vial lyophilizer, vial capping machine, etc., as well as R & D laboratories, physical and chemical testing room, microbiology testing room.

Relying on the world's first protein polymer biotechnology (ECIWEP) of Darwin Cell Biology Group, Darwin Nogol has realized the production conditions covering orthopedics, neurology and dermatology biomaterials. Collagen" as the core raw material for joint repair products developed by collagen composite materials with local injection without surgery, simple operation with fewer complications, short recovery time and no impact on life and other clinical advantages, to fill the blank of domestic collagen for joint injury repair, creating a new treatment method for joint injury repair. It has created a new treatment method for joint injury repair.

Collagen composites obtained Class III Medical Device Classification Definition in 2022, and has passed the safety test of the State Food and Drug Administration Guangzhou Medical Device Quality Supervision and Inspection Center and the registration test of the China Academy of Food and Drug Control. Collagen composites have obtained hospital ethical review approval, and in August 2024 entered the clinical trial stage.

On June 21, 2024, the project "Recombinant Collagen Scaffold Material" of Darwin Nogol (Beijing) Biotechnology Co., Ltd. was awarded the "Best Collagen Scaffold Material" award for its unique innovativeness and significant social value.Third Prize of Advanced Manufacturing Project Group in the 6th "China Wings of Entrepreneurship and Innovation Competition" Beijing Selection Competition and the 7th "Entrepreneurship Beijing" Entrepreneurship and Innovation Competition and the 5th Entrepreneurship and Innovation Competition of Shijingshan District.